-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 13, the association invited the State Pharmacopoeia Commission, Zhejiang Institute of Food and Drug Inspection, Guangdong Drug Inspection Institute, and related enterprises of the Association's hollow capsule professional committee to discuss the changing trend of domestic and foreign standards for hollow capsul.
Yu Hui and Chen Yue, the two directors of the Institute of Excipients and Packaging Materials of Zhejiang Provincial Institute for Drug Control, introduced the development history and standardization work of Zhejiang Institute and Zhejiang Capsule Enterpris.
Ten companies from the Association's Hollow Capsule Special Committee made speeches on the revision of the "Chinese Pharmacopoeia" capsule standard, the implementation of the Association's capsule standard, the trend of foreign capsule standards and the replacement of titanium dioxide in the .
The participants of the National Pharmacopoeia Committee put forward several suggestions on the capsule standard work: First of all, it is hoped that industry associations and member units will open their minds and actively participate in the revision of the capsule standard of the 2025 edition of the Chinese Pharmacopoe.
Secondly, for the series standards of gelatin for capsules, hollow gelatin capsules and enteric-coated gelatin capsules that have been included in the Chinese Pharmacopoeia, systematic review and comprehensive consideration are carried o.
At the same time, it is hoped that the drafting unit of the Pharmacopoeia standard will cooperate closely with the industry association to carry out special investigations on issues such as sterilization process optimization, capsules for inhalation preparations, and titanium dioxide replaceme.
Based on the trial basis of group standards, the quality control of capsules will be introduced into the Chinese Pharmacopoeia in due cour.
Guiding principles to form a positive interaction between national standards and group standards, better urge enterprises to implement their main responsibilities, and ensure the safety of public medicati.
